- Home
- PGEN vs DPG Comparison
PGEN vs DPG Comparison
Compare PGEN & DPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- DPG
- Stock Information
- Founded
- PGEN 1998
- DPG 2011
- Country
- PGEN United States
- DPG United States
- Employees
- PGEN N/A
- DPG N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- DPG Trusts Except Educational Religious and Charitable
- Sector
- PGEN Health Care
- DPG Finance
- Exchange
- PGEN Nasdaq
- DPG Nasdaq
- Market Cap
- PGEN 493.0M
- DPG 462.7M
- IPO Year
- PGEN N/A
- DPG N/A
- Fundamental
- Price
- PGEN $3.82
- DPG $12.41
- Analyst Decision
- PGEN Buy
- DPG
- Analyst Count
- PGEN 5
- DPG 0
- Target Price
- PGEN $7.50
- DPG N/A
- AVG Volume (30 Days)
- PGEN 9.2M
- DPG 150.1K
- Earning Date
- PGEN 11-13-2025
- DPG 01-01-0001
- Dividend Yield
- PGEN N/A
- DPG 9.09%
- EPS Growth
- PGEN N/A
- DPG N/A
- EPS
- PGEN N/A
- DPG N/A
- Revenue
- PGEN $4,340,000.00
- DPG N/A
- Revenue This Year
- PGEN $253.63
- DPG N/A
- Revenue Next Year
- PGEN $699.64
- DPG N/A
- P/E Ratio
- PGEN N/A
- DPG N/A
- Revenue Growth
- PGEN N/A
- DPG N/A
- 52 Week Low
- PGEN $0.65
- DPG $7.90
- 52 Week High
- PGEN $5.23
- DPG $13.58
- Technical
- Relative Strength Index (RSI)
- PGEN 54.30
- DPG 37.00
- Support Level
- PGEN $3.47
- DPG $12.46
- Resistance Level
- PGEN $4.14
- DPG $12.77
- Average True Range (ATR)
- PGEN 0.35
- DPG 0.13
- MACD
- PGEN -0.16
- DPG -0.03
- Stochastic Oscillator
- PGEN 19.89
- DPG 0.00
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting from a high level of current income, with an emphasis on providing tax-advantaged dividend income.